The Total Number of Retroperitoneal Lymph Nodes Resected Impacts Clinical Outcome After Chemotherapy for Metastatic Testicular Cancer

Urology

Volumn 75, Issue 6, 2010, Pages 1431-1435

  Carver, Brett S ^a   Cronin, Angel M ^a   Eggener, Scott ^a   Savage, Caroline J ^a   Motzer, Robert J ^a   Bajorin, Dean ^a   Bosl, George J ^a   Sheinfeld, Joel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CONTROLLED STUDY; FIBROSIS; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; TESTIS CANCER; TESTIS TERATOMA;

ADULT; BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DATABASES, FACTUAL; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ORCHIECTOMY; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TERATOMA; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952746035     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.11.076     Document Type: Article

References (16)

1. Bosl G., Bajorin D., Sheinfeld J., et al. Cancer of the testis. In: Devita Y., Hellman S., and Rosenberg S. (Eds). Cancer: Principles and Practice of Oncology (2000), JB Lippincott, Philadelphia, PA 1491-1518
2. Toner G.C., Panicek D.M., Heelan R.T., et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8 (1990) 1683-1694
3. Carver B.S., Serio A.M., Bajorin D., et al. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J Clin Oncol 25 (2007) 5603-5608
4. Johnson P.M., Porter G.A., Ricciardi R., et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24 (2006) 3570-3575
5. Touijer K., Rabbani F., Otero J.R., et al. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. J Urol 178 (2007) 120-124
6. Briganti A., Chun F.K., Salonia A., et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 69 (2007) 147-151
7. Koppie T.M., Vickers A.J., Vora K., et al. Standardization of pelvic lymphadenectomy performed at radical cystectomy. Cancer 107 (2006) 2368-2374
8. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252-2255
9. Beck S.D., Foster R.S., Bihrle R., et al. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?. Cancer 110 (2007) 1235-1240
10. Steiner H., Peschel R., and Bartsch G. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary?. BJU Int 102 (2008) 310-314
11. Carver B.S., Shayegan B., Eggener S., et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 25 (2007) 4365-4369
12. International Germ Cell Cancer Collaborative Group (IGCCCG). International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15 (1997) 594-603
13. Jewett M.A., Kong Y.S., Goldberg S.D., et al. Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139 (1988) 1220-1224
14. Pettus J.A., Carver B.S., Masterson T., et al. Preservation of ejaculation in patients undergoing nerve-sparing post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology 73 (2009) 328-331
15. Stein J.P., Penson D.F., Cai J., et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177 (2007) 876-881
16. Bochner B.H., Cho D., Herr H.W., et al. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172 (2004) 1286-1290